ATLAS SP Partners, majority owned by Apollo funds, announced the pricing of $750 million senior notes due 2032 with a fixed 6.25% interest rate until November 2031, then switching to a floating rate based on SOFR plus a spread. The notes, issued by Atlas Warehouse Lending Company, L.P., will mature in 2032 and are guaranteed by AWLC's subsidiaries. Proceeds will fund assets, cover fees, and possibly repay debt. The offering targets qualified institutional buyers and is expected to close on October 21, 2026.
The AWLC senior notes pricing provides context for the Financials sector on Pluang. For readers following Financials, here is Pluang's market snapshot as of Oct 15, 2026 04:41 WIB: Out of 142 priced Financials-sector US stocks, 24 rose and 118 fell. Among notable movers, BTBT dropped 11.16% to USD 1.07 with a 54% sell order activity, contrasting with MARA which fell 9.88% to USD 8.21 but had 100% buy order activity, and AFRM declined 9.81% to USD 70.25.
Stephany Insurance LLC, a fourth-generation independent agency in Wexford, PA, is highlighted in a new 2026 guide for helping small businesses in Pittsburgh's North Hills identify and close insurance coverage gaps caused by rising premiums. The guide...
The Knowles-Rowland House, a $13.96 million redevelopment project by Bread of Life Inc., has opened in Midtown Houston, providing 31 permanent supportive housing units for individuals exiting chronic homelessness. The building, formerly a fire-damage...
Bending Spoons led market gainers with a 41.2% rise after Berkshire Hathaway increased its stake to 4% by investing an additional $330 million. Antelope Enterprise gained 36.4%, and NEXGEL rose 32.1% following a reverse stock split. Liquidia advanced...
The Law Offices of Frank R. Cruz is investigating Alignment Healthcare following a whistleblower lawsuit claiming the company misclassified $8-10 million in expenses to inflate its adjusted EBITDA and stock price. This alleged accounting manipulation...
Lakefront Biotherapeutics has completed the sale of its preclinical CAR-T cell therapy programs to Belgium-based Armed Cell Therapeutics. The deal includes an upfront payment of €8 million, potential milestone payments up to $230 million, and a low s...
